ArticleJAC-antimicrobial resistance2023

Health-economic modelling of cost savings due to the use of rezafungin based on a German cost-of-illness study of candidiasis.

Julia Jeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.